RALLYBIO CORP (RLYB) Stock Income Statement
NASDAQ:RLYB - US75120L1008 - Common Stock
0.5366 USD
-0.02 (-4.21%)
0.5405 USD
+0 (+0.73%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 761.00K | 636.00K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 44.16M | 61.13M | 78.93M | 67.88M | 45.64M | |||
| Research and Development | 27.42M | 41.51M | 53.54M | 40.69M | 26.91M | |||
| Selling, General, and Administrative Expenses | 16.74M | 19.63M | 25.39M | 27.20M | 18.74M | |||
| Operating Income | -43.40M | -60.50M | -78.93M | -67.88M | -45.64M | |||
| Interest Income/Expense | 2.96M | 4.22M | 6.15M | 1.96M | 40.00K | |||
| Other Income/Expense | 726.00K | 744.00K | 262.00K | 340.00K | 100.00K | |||
| Non Recurring Items | -1.94M | -2.24M | -2.04M | -1.08M | -1.51M | |||
| Income Before Taxes | -41.65M | -57.77M | -74.56M | -66.65M | -47.01M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -41.65M | -57.77M | -74.56M | -66.65M | -47.01M | |||
| EBITDA | -43.28M | -60.37M | -78.78M | -67.71M | -45.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.93 | -1.33 | -1.84 | -2.09 | -1.84 | |||
| Non GAAP EPS | -0.94 | -1.35 | -1.84 | -2.11 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -5473.32% | -9084.12% | N/A | N/A | N/A | |||
| Operating Profit Margin | -5703.15% | -9511.95% | N/A | N/A | N/A | |||
All data in USD